I wish you a warm welcome to the symposium ”Cardiometabolic Risk and Vascular Disease: from Mechanisms to Treatment” here in Stockholm from 1-3 December 2017. This three-day programme offers a comprehensive update of cardiometabolic risk presented by a distinguished international teaching faculty.
The educational objectives are to review and disseminate the latest knowledge about advances in the pathophysiology, diagnosis and treatment of cardiometabolic risk and to discuss its impact in clinical practice. The scientific programme covers a broad spectrum of topics including the relationship between immunity and metabolism as well as inflammation and atherosclerosis; preventive strategies; evidence-based management of obesity and insulin resistance; atherothrombosis and strategies beyond glycemic control; diabetes, acute coronary syndromes and heart failure. State of the art lectures alternate with interactive sessions.
Our Symposium is designed to promote a working and learning environment across specialty borders.
I am looking forward to meeting you in Stockholm.